NCT03951805 - A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before | Biotech Hunter

Enrollment

205

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

January 17, 2020

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin icodec

Administered subcutaneously SC once weekly. Starting dose will be 70U.

DRUG

Insulin Glargine

Administered subcutaneously SC once daily.The starting dose will be 10U.

Trial Locations (43)

7400

Novo Nordisk Investigational Site, Kaposvár

8900

Novo Nordisk Investigational Site, Zalaegerszeg

14224

Novo Nordisk Investigational Site, West Seneca

14612

Novo Nordisk Investigational Site, Falkensee

15006

Novo Nordisk Investigational Site, A Coruña

22607

Novo Nordisk Investigational Site, Hamburg

23758

Novo Nordisk Investigational Site, Oldenburg I. Holst

30076

Novo Nordisk Investigational Site, Roswell

30461

Novo Nordisk Investigational Site, Statesboro

35415

Novo Nordisk Investigational Site, Pohlheim

37203

Novo Nordisk Investigational Site, Nashville

37411

Novo Nordisk Investigational Site, Chattanooga

45136

Novo Nordisk Investigational Site, Essen

47000

Novo Nordisk Investigational Site, Karlovac

48145

Novo Nordisk Investigational Site, Münster

48903

Novo Nordisk Investigational Site, Barakaldo

66299

Novo Nordisk Investigational Site, Friedrichsthal

66386

Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach

75231

Novo Nordisk Investigational Site, Dallas

78154

Novo Nordisk Investigational Site, Schertz

78731

Novo Nordisk Investigational Site, Austin

89128

Novo Nordisk Investigational Site, Las Vegas

92801

Novo Nordisk Investigational Site, Anaheim

93201

Novo Nordisk Investigational Site, Veľký Meder

93534

Novo Nordisk Investigational Site, Lancaster

94911

Novo Nordisk Investigational Site, Nitra

97401

Novo Nordisk Investigational Site, Banská Bystrica

97901

Novo Nordisk Investigational Site, Rimavská Sobota

97980

Novo Nordisk Investigational Site, Bad Mergentheim

75390-9302

Novo Nordisk Investigational Site, Dallas

31 000

Novo Nordisk Investigational Site, Osijek

51 000

Novo Nordisk Investigational Site, Rijeka

42 000

Novo Nordisk Investigational Site, Varaždin

H-6725

Novo Nordisk Investigational Site, Szeged

15-435

Novo Nordisk Investigational Site, Bialystok

20-538

Novo Nordisk Investigational Site, Lublin

26-600

Novo Nordisk Investigational Site, Radom

97-200

Novo Nordisk Investigational Site, Tomaszów Mazowiecki

02-507

Novo Nordisk Investigational Site, Warsaw

040 01

Novo Nordisk Investigational Site, Košice

04801

Novo Nordisk Investigational Site, Rožňava

08430

Novo Nordisk Investigational Site, La Roca Del Vallés

08500

Novo Nordisk Investigational Site, Vic (Barcelona)